AI-driven Lab Automation Market Revenue and Forecast by 2033
Published: 26 Nov 2025
Author: Precedence Research
AI-driven Lab Automation Market Revenue and Trends 2025 to 2033
The global AI-driven lab automation market enhances pharmaceutical and research labs with next-gen automation and machine learning. The market is expanding significantly globally as governments increase healthcare expenditure to develop and integrate AI-powered technologies to accelerate lab automation, aiming to combat rising chronic diseases with greater efficiency and lower costs.
What Are the Factors That Have a Significant Contribution to the Growth of the AI-driven Lab Automation Market?
The AI-driven lab automation market is growing due to rising R&D spending in pharmaceuticals, biotech, and life sciences research; government efforts to modernize laboratories to combat the rising prevalence of chronic diseases; and increasing demand for data analysis. AI can significantly reduce processing time, handle high-throughput screening, and streamline workflows, all of which are critical to drug discovery and diagnostic methods.
Demand for lab technicians has grown significantly over the last few years, while supply has fallen short, a problem that can be addressed through lab automation. The increasing focus on personalized treatments needs highly precise automated systems for complex genetic analysis. Emerging economies are also increasingly adopting lab automation with government-backed initiatives and huge investments, further accelerating the markets growth.
Segment Insights
- By process type, the continuous flow processing segment dominated the market due to the faster results and higher-quality output it delivers for large samples, even with a small number of chemistries.
- By application, the drug discovery and development segment held the largest market share, owing to the potential of AI-powered data analysis, which minimizes overall processing costs and delivers faster results for laboratory experiments without continuous human intervention.
- By automation type, modular automation dominated the global AI-driven lab automation market, as it offers high scalability and flexibility that help meet customized laboratory targets.
- By end user, the pharmaceutical and biotech segment held the largest market share due to the increasing government support for AI integration into laboratory workings to develop new drugs.
Regional Insights
Regionally, North America held the largest market share in 2024 due to significant funding from governments, private equity and venture capital, along with highly advanced healthcare and pharma sectors that are already well developed in the region. The presence of a highly skilled workforce and robust infrastructure, with active tech giants constantly innovating and redefining technologies such as AI and robotics, which can be integrated into laboratories. These factors are reinforced by strong institutional ecosystems, including major research universities, NIH-funded laboratories and advanced clinical networks that adopt automation platforms early.
Large companies such as Thermo Fisher Scientific, Illumina, Beckman Coulter and Agilent Technologies continue to scale integrated AI-based systems for diagnostics, drug discovery and high-throughput screening, which accelerates adoption across hospital networks and biotechnology hubs. Furthermore, the region benefits from strong regulatory clarity, established digital health frameworks and widespread availability of cloud computing resources, making North America the most mature market for AI-driven automated laboratory systems.
Asia Pacific is the fastest growing region in the global AI-driven lab automation market due to strong government funding for digitalization across leading sectors, emerging economies interested in adopting cutting-edge technologies to address real-life issues such as chronic diseases and the rapid adoption of AI in laboratory development. Emerging countries like Japan, India and China are market frontiers, advancing with policies such as Made in China 2025 that further fuel the region’s growth while embracing technologies for lab automation.
National initiatives, including Japan’s Society 5.0 roadmap, India’s Digital Health Mission and China’s 14th Five-Year Plan, encourage the deployment of AI-enabled diagnostic platforms, smart biomanufacturing and high-throughput genomic workflows. Regional institutions such as RIKEN, the National University of Singapore and India’s Centre for Cellular and Molecular Platforms are increasing investments in robotic liquid handling, automated PCR systems and cloud-based laboratory management tools. In parallel, local industry players such as Mindray, Sysmex and Samsung Biologics are accelerating the commercialization of AI-supported laboratory systems, creating rapid adoption across clinical diagnostics, pharmaceuticals and precision medicine programs.
AI-driven Lab Automation Market Coverage
| Report Attribute | Key Statistics |
| Quantitative Units | Revenue in USD million/billion, Volume in units |
| Largest Market | North America |
| Base Year | 2024 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa |
Recent Development
- In November 2025, Telescope Innovations Corp announces that the pharmaceutical and biopharmaceutical association has purchased self-driving lab platforms offered by Telescope, aiming to install a new R&D facility in Seoul.(Source: https://www.newsfilecorp.com)
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7144
You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344